D-BOX Technologies’ Fourth Quarter Caps Record Year for Revenue and Net Profit
May 30, 2024 17:01 ET
|
D-BOX Technologies Inc.
Haptics leader is focused on accelerating profitable growth MONTREAL, May 30, 2024 (GLOBE NEWSWIRE) -- D-BOX Technologies Inc. (“D-BOX” or the "Corporation") (TSX: DBO) a world leader in haptic and...
BiomX Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
May 30, 2024 16:50 ET
|
BiomX
GAITHERSBURG, Md. and NESS ZIONA, Israel, May 30, 2024 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and...
Pharming Group provides update on ongoing regulatory review of leniolisib for the treatment of APDS in the European Union
May 30, 2024 16:44 ET
|
Pharming Group N.V.
Leiden, the Netherlands, May 30, 2024: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces today an update on the ongoing review of its Marketing...
DBV Technologies participera au prochain congrès EAACI 2024
May 30, 2024 16:30 ET
|
DBV Technologies S.A.
Châtillon, France, le 30 mai (22h30 CEST) 2024 DBV Technologies participera au prochain congrès EAACI 2024 DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq Stock Market : DBVT), une...
American Lithium Announces Financial and Operating Highlights for Year and Quarter Ended February 29, 2024
May 30, 2024 16:30 ET
|
American Lithium Corp.
VANCOUVER, British Columbia, May 30, 2024 (GLOBE NEWSWIRE) -- American Lithium Corp. (“American Lithium” or the “Company”) (TSX-V:LI | Nasdaq:AMLI | Frankfurt:5LA1) is pleased to provide financial...
Red White & Bloom Reports First Quarter 2024 Financial Results
May 30, 2024 16:30 ET
|
Red White & Bloom Brands Inc.
Red White & Bloom Brands Inc. has filed its interim financial statements and MD&A for the first quarter ended March 31, 2024.
Supernus Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
May 30, 2024 16:25 ET
|
Supernus Pharmaceuticals, Inc.
ROCKVILLE, Md., May 30, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of...
Larimar Therapeutics Selected by FDA to Participate in START Pilot Program for Nomlabofusp in Friedreich’s Ataxia
May 30, 2024 16:05 ET
|
Larimar Therapeutics
START is a new milestone-driven program designed to accelerate development of novel therapies intended to address an unmet medical need for rare diseasesNomlabofusp was selected based on potential for...
NextCure Presents Phase 1b Data on NC410 and Pembrolizumab Combination at ASCO 2024
May 30, 2024 16:05 ET
|
NextCure
Of the evaluable ICI-naïve MSS/MSI-L CRC patients without liver metastasis, there were 2 confirmed ongoing PRs and a disease control rate of 51%Of the 7 evaluable ovarian cancer patients, there were 3...
Caribou Biosciences to Host KOL Discussion with Webcast from the 2024 ASCO Annual Meeting and Participate in Upcoming Investor Conferences
May 30, 2024 16:01 ET
|
Caribou Biosciences, Inc.
BERKELEY, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced the company’s...